How does antibiotic resistance make bacterial sexually transmitted diseases harder to treat?

Antibiotic resistance significantly complicates the treatment of bacterial sexually transmitted diseases (STDs) by rendering standard, previously effective medications ineffective. When bacteria are exposed to antibiotics, sensitive strains are eradicated, allowing resistant variants to survive, multiply, and proliferate.123

This resistance makes treatment harder in several ways:

• Reduced Efficacy: Infections may no longer respond to customary antibiotics, forcing clinicians to rely on alternative, often more complex, or expensive drug regimens.123
• Multidrug Resistance: As seen with Neisseria gonorrhoeae, bacteria can develop resistance to multiple classes of antibiotics, leading to the emergence of multidrug-resistant strains that are increasingly difficult to eliminate.1
• Complex Therapy: To combat resistance, medical professionals often must employ dual drug therapy—using combinations of antibiotics to increase the likelihood of success—which can be more difficult to manage and may increase the risk of side effects.1
• Treatment Delays: The need to identify specific resistant strains through susceptibility testing can delay the administration of the most effective treatment, potentially allowing the infection to progress or spread to others.14

Addressing this issue is a critical public health priority, as the indiscriminate use of antibiotics continues to drive the evolution of these resistant pathogens.23